Signaling pathway strategy offers a new approach for treating prostate cancer
Prostate cancer is the second most common cancer in men worldwide. Despite medical advances in recent years, this type of ...
Key pathway leading to neurodegeneration in early stages of ALS identified
Approximately 5,000 people in the U.S. develop amyotrophic lateral sclerosis (ALS) each year. On average, they survive for ...
PharmTech18h
J&J’s Balversa Gains MHRA Marketing Authorization as Monotherapy for Bladder Cancer
and who have previously received at least one line of therapy containing a programmed death receptor-1 (PD-1) or programmed death-ligand 1 (PD-L1) inhibitor in the unresectable or metastatic treatment ...